Cardiovascular Systems posted a GAAP loss of $2.076 million in the 3 months of fiscal 2021, a 64.1% decrease from $5.78 million in the previous year. Revenue decreased 6.1% to $60.544 million, down from $64.49 million a year earlier.
Cardiovascular Systems posted a GAAP loss of $2.076 million in the 3 months of fiscal 2021, a 64.1% decrease from $5.78 million in the previous year. Revenue decreased 6.1% to $60.544 million, down from $64.49 million a year earlier. 
investors.csi360.com
English (US) 